MediWound price target lowered to $25 from $28 at H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on MediWound (MDWD) to $25 from $28 and keeps a Buy rating on the shares following the Q3 report. The firm says NexoBrid supply may soon meet demand.